Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03228290 · ClinicalTrials.gov registry record
Functional Assessment in Liver Transplantation
A clinical trial of End Stage Liver DIsease, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 12
- Study locations
NCT03228290: Recruiting study of End Stage Liver DIsease, sponsored by University of California, San Francisco.
NCT03228290 is a study of End Stage Liver DIsease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 5,000 participants, above the 179-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (2693% higher). The trial reports 12 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03228290, a study of End Stage Liver DIsease, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 12
- Study locations
Study Summary
This will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of frailty, functional status, and disability using functional status measures at baseline and at every clinic visit in the pre-transplant setting. Subjects will also answer questions regarding quality of life, personality, and/or cognitive function. Subjects will again undergo assessments at every clinic visit through 12 months after transplant. Then, they will be followed annually.
Primary Outcome
Grip strength: Performance-based. Measured in kilograms. This was measured in each subject's dominant hand using a hand dynamometer (Jamar Hydraulic hand dynamometer). We averaged three trials. Chair stands: Performance-based. Measured in number of chair stands per second. Number of chair stands completed in 30 seconds. Balance: Performance-based. Measured in seconds. Ability to balance in three positions (feet placed side to side, semitandem, and tandem) for 10 seconds each. Liver Frailty In
Conditions Studied
Study Locations (12)
California
- Loma Linda University - Loma Linda
- University of California, San Francisco - San Francisco
Arkansas
- University of Arkansas for Medical Sciences - Little Rock
Illinois
- Northwestern University - Chicago
Indiana
- Indiana University - Indianapolis
Maryland
- Johns Hopkins - Baltimore
Michigan
- University of Michigan - Ann Arbor
New York
- Columbia University - New York
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2011-10-12 |
| Est. Completion | 2028-12-31 |
What NCT03228290 shows while recruiting
NCT03228290 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 179-participant average among 16 other End Stage Liver DIsease trials with a reported enrollment target (2693% higher).
The record links to 1 condition, with End Stage Liver DIsease appearing as the primary indexed condition, and to 0 interventions.
NCT03228290 lists 12 locations in 11 states (California, Arkansas, Illinois).
Frequently Asked Questions
What is clinical trial NCT03228290 about?
NCT03228290 is a clinical study titled "Functional Assessment in Liver Transplantation". This will be a prospective cohort study of patients with liver disease. Subjects will undergo geriatric assessments of frailty, functional status, and disability using functional status measures at baseline and at every clinic visit in the pre-transplant setting. Subjects will also answer questions ...
What is the current status of trial NCT03228290?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2011-10-12. Estimated completion is 2028-12-31.
What conditions does trial NCT03228290 study?
This clinical trial studies the following conditions: End Stage Liver DIsease.
Who is sponsoring clinical trial NCT03228290?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03228290 being conducted?
This trial has 12 study locations across Arkansas, California, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for End Stage Liver DIsease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03228290's enrollment target sits among peer trials
5,000 1st of 16 higher than 16 of 16 other End Stage Liver DIsease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other End Stage Liver DIsease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Disparities Among Liver Transplant Patients
RECRUITING
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
Adverse Outcomes and Mortality in Liver Transplant
RECRUITING · NA
-
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
RECRUITING · NA
-
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
RECRUITING · NA
-
A Study of SIPLIZUMAB in AILD and LT Patients
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI